Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 2 |
2014 | 3 |
2015 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Warfarin pharmacogenetics: to genotype or not to genotype, that is the question.
Clin Pharmacol Ther. 2014 Jul;96(1):22-4. doi: 10.1038/clpt.2014.78.
Clin Pharmacol Ther. 2014.
PMID: 24942399
Review.
Personalized medicine in cardiology: the time for genotype-guided therapy is now.
Cavallari LH, Nutescu EA, Duarte JD.
Cavallari LH, et al.
Future Cardiol. 2013 Jul;9(4):459-64. doi: 10.2217/fca.13.35.
Future Cardiol. 2013.
PMID: 23834684
Review.
No abstract available.
Item in Clipboard
Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum.
Nutescu EA, Wittkowsky AK, Burnett A, Merli GJ, Ansell JE, Garcia DA.
Nutescu EA, et al.
Ann Pharmacother. 2013 May;47(5):714-24. doi: 10.1345/aph.1R634. Epub 2013 Apr 12.
Ann Pharmacother. 2013.
PMID: 23585642
Free PMC article.
Item in Clipboard
Evaluation of dabigatran bleeding adverse reaction reports in the FDA adverse event reporting system during the first year of approval.
McConeghy KW, Bress A, Qato DM, Wing C, Nutescu EA.
McConeghy KW, et al.
Pharmacotherapy. 2014 Jun;34(6):561-9. doi: 10.1002/phar.1415. Epub 2014 Mar 19.
Pharmacotherapy. 2014.
PMID: 24644100
Item in Clipboard
Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.
Drozda K, Wong S, Patel SR, Bress AP, Nutescu EA, Kittles RA, Cavallari LH.
Drozda K, et al.
Pharmacogenet Genomics. 2015 Feb;25(2):73-81. doi: 10.1097/FPC.0000000000000108.
Pharmacogenet Genomics. 2015.
PMID: 25461246
Free PMC article.
Item in Clipboard
Relationship between time spent at extreme International Normalized Ratios and time in therapeutic range with bleeding and thrombosis in warfarin-treated patients.
Barta AL, Nutescu EA, Thompson PA, Bussey HI, Gulseth MP.
Barta AL, et al.
Am J Health Syst Pharm. 2015 Jul 15;72(14):1188-94. doi: 10.2146/ajhp140752.
Am J Health Syst Pharm. 2015.
PMID: 26150568
Item in Clipboard
Warfarin dose requirements in a patient with the CYP2C9*14 allele.
Lee YM, Eggen J, Soni V, Drozda K, Nutescu EA, Cavallari LH.
Lee YM, et al.
Pharmacogenomics. 2014 May;15(7):909-14. doi: 10.2217/pgs.14.47.
Pharmacogenomics. 2014.
PMID: 24956244
Free PMC article.
Item in Clipboard
Cite
Cite